Abstract
We wish to respond to the article “Going native, or the risk of overreliance on recombinant antigens” ([1][1]) by Dr. Lopez-Perez, which questions our findings that antibodies to VAR2CSA can arise outside pregnancy. She asserts that relying on antibody recognition of recombinant proteins can
Highlights
Lopez-Perez, which questions our findings that antibodies to VAR2CSA can arise outside pregnancy
She asserts that relying on antibody recognition of recombinant proteins can yield misleading data on VAR2CSA antibody responses
We contend that the most important way to characterize VAR2CSA antibodies is not based exclusively on antigen recognition but on whether those antibodies block the adhesion of infected erythrocytes (IE) to the placental receptor chondroitin sulfate A (CSA)
Summary
We wish to respond to the article “Going native, or the risk of overreliance on recombinant antigens” [1] by Dr Lopez-Perez, which questions our findings that antibodies to VAR2CSA can arise outside pregnancy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.